Olson William C 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 5, 2012
Insider Transaction Report
Form 4
Olson William C
VP, Research & Development
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2012-03-01$9.81/sh+50,000$490,500→ 50,000 totalExercise: $9.81Exp: 2022-03-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.